ZA909305B - Heterocyclic carboxylic acids - Google Patents
Heterocyclic carboxylic acidsInfo
- Publication number
- ZA909305B ZA909305B ZA909305A ZA909305A ZA909305B ZA 909305 B ZA909305 B ZA 909305B ZA 909305 A ZA909305 A ZA 909305A ZA 909305 A ZA909305 A ZA 909305A ZA 909305 B ZA909305 B ZA 909305B
- Authority
- ZA
- South Africa
- Prior art keywords
- image
- carboxylic acids
- alkyl
- alkoxy
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Indole Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK588189A DK588189D0 (da) | 1989-11-22 | 1989-11-22 | Nye heterocykliske carboxylsyrer |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA909305B true ZA909305B (en) | 1991-09-25 |
Family
ID=8145900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA909305A ZA909305B (en) | 1989-11-22 | 1990-11-20 | Heterocyclic carboxylic acids |
Country Status (16)
Country | Link |
---|---|
US (1) | US5198451A (da) |
EP (1) | EP0502031B1 (da) |
JP (1) | JPH05503083A (da) |
AT (1) | ATE157086T1 (da) |
AU (1) | AU660919B2 (da) |
CA (1) | CA2073189C (da) |
DE (1) | DE69031312T2 (da) |
DK (2) | DK588189D0 (da) |
FI (1) | FI97541C (da) |
IE (1) | IE904155A1 (da) |
IL (2) | IL96370A0 (da) |
NO (1) | NO177853C (da) |
NZ (1) | NZ236155A (da) |
PT (1) | PT95970B (da) |
WO (1) | WO1991007389A1 (da) |
ZA (1) | ZA909305B (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK74693D0 (da) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
US5962449A (en) | 1995-04-07 | 1999-10-05 | Novo Nordisk A/S | Tricyclic compounds in treating hyperalgesic conditions and NIDDM |
JP2000511538A (ja) * | 1996-05-24 | 2000-09-05 | スミスクライン・ビーチャム・コーポレイション | 鎮咳剤としてのgaba取り込み阻害剤の使用 |
DE10204496A1 (de) * | 2002-02-04 | 2003-08-21 | Msa Auer Gmbh | Vorrichtung zur Dosierung gas- und/oder dampfförmiger Stoffe |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4383999A (en) * | 1981-05-26 | 1983-05-17 | Smithkline Beckman Corporation | Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters |
DK704488D0 (da) * | 1988-12-19 | 1988-12-19 | Novo Industri As | Nye n-substituerede azaheterocykliske carboxylsyrer |
DK288385D0 (da) * | 1985-06-26 | 1985-06-26 | Novo Industri As | Aminosyrederivater |
FI864246A (fi) * | 1985-11-08 | 1987-05-09 | Warner Lambert Co | N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat. |
US4772615A (en) * | 1985-11-08 | 1988-09-20 | Warner-Lambert Company | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof |
US4910312A (en) * | 1985-11-08 | 1990-03-20 | Warner-Lambert Company | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof |
PT84064B (pt) * | 1986-01-07 | 1989-07-31 | Novo Industri As | Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem |
US5006560A (en) * | 1989-12-20 | 1991-04-09 | Schering Corporation | Use of GABA-B selective agonists as anti-tussive agents |
-
1989
- 1989-11-22 DK DK588189A patent/DK588189D0/da not_active Application Discontinuation
-
1990
- 1990-11-16 IL IL69370A patent/IL96370A0/xx unknown
- 1990-11-16 IL IL9637090A patent/IL96370A/en not_active IP Right Cessation
- 1990-11-19 IE IE415590A patent/IE904155A1/en unknown
- 1990-11-20 NZ NZ236155A patent/NZ236155A/xx unknown
- 1990-11-20 ZA ZA909305A patent/ZA909305B/xx unknown
- 1990-11-20 US US07/616,165 patent/US5198451A/en not_active Expired - Fee Related
- 1990-11-22 PT PT95970A patent/PT95970B/pt active IP Right Grant
- 1990-11-22 AU AU67464/90A patent/AU660919B2/en not_active Ceased
- 1990-11-22 EP EP90917178A patent/EP0502031B1/en not_active Expired - Lifetime
- 1990-11-22 AT AT90917178T patent/ATE157086T1/de active
- 1990-11-22 DE DE69031312T patent/DE69031312T2/de not_active Expired - Fee Related
- 1990-11-22 JP JP3500073A patent/JPH05503083A/ja active Pending
- 1990-11-22 DK DK90917178.7T patent/DK0502031T3/da active
- 1990-11-22 WO PCT/DK1990/000302 patent/WO1991007389A1/en active IP Right Grant
- 1990-11-22 CA CA002073189A patent/CA2073189C/en not_active Expired - Fee Related
-
1992
- 1992-05-11 NO NO921852A patent/NO177853C/no unknown
- 1992-05-19 FI FI922268A patent/FI97541C/fi active
Also Published As
Publication number | Publication date |
---|---|
NO177853C (no) | 1995-12-06 |
NO921852L (no) | 1992-05-11 |
CA2073189C (en) | 1998-04-07 |
NO921852D0 (no) | 1992-05-11 |
WO1991007389A1 (en) | 1991-05-30 |
IE904155A1 (en) | 1991-05-22 |
NO177853B (no) | 1995-08-28 |
DK0502031T3 (da) | 1998-03-30 |
US5198451A (en) | 1993-03-30 |
JPH05503083A (ja) | 1993-05-27 |
FI97541C (fi) | 1997-01-10 |
DE69031312D1 (de) | 1997-09-25 |
FI97541B (fi) | 1996-09-30 |
FI922268A (fi) | 1992-05-19 |
EP0502031A1 (en) | 1992-09-09 |
IL96370A (en) | 1995-01-24 |
AU6746490A (en) | 1991-06-13 |
IL96370A0 (en) | 1991-08-16 |
PT95970B (pt) | 1998-01-30 |
ATE157086T1 (de) | 1997-09-15 |
DE69031312T2 (de) | 1998-02-26 |
AU660919B2 (en) | 1995-07-13 |
PT95970A (pt) | 1991-09-13 |
CA2073189A1 (en) | 1991-05-23 |
FI922268A0 (fi) | 1992-05-19 |
DK588189D0 (da) | 1989-11-22 |
EP0502031B1 (en) | 1997-08-20 |
NZ236155A (en) | 1993-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59401923D1 (de) | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel | |
IL87795A (en) | Benzimidazolin-2-oxo- 1-carboxylic acid ester and amide derivatives, their preparation and pharmaceutical compositions containing them | |
ZA934997B (en) | Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives | |
MX9707531A (es) | Nuevos compuestos heterociclicos. | |
JP2005504729A5 (da) | ||
EP0344682A3 (de) | Oligopeptide mit zyklischen Prolin-analogen Aminosäuren | |
ATE285403T1 (de) | Verfahren zur herstellung von n-((4- phenyl)methylphenyl)piperazinen | |
HUT57773A (en) | Process for produicng n-(aminocarbonyl)-carbamates related to physostigmine, as well as pharmaceutical compositions comprising such compounds | |
ZA909305B (en) | Heterocyclic carboxylic acids | |
FI101301B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi | |
GR3030364T3 (en) | Indole-7-carboxamide derivatives as analgesics. | |
PL233059A1 (da) | ||
PT1021404E (pt) | Derivados de azetidinona para o tratamento de infeccoes pelo hcmv | |
ATE212637T1 (de) | Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung | |
HU895648D0 (en) | Process for the preparation of n,n-disubstituted diaryl-alkancarboxylic acid amide derivatives and pharmaceutical compositions containing such compounds | |
KR960704888A (ko) | AMPA-수용체에 작용하는 알콕시-치환 β-카르보린 (Alkoxy-Substituted β-Carbolines Acting on The AMPA-Receptor) | |
NO903927D0 (no) | N-azabicyklo(3.3.0)oktan-amider av aromatiske syrer. | |
NZ331180A (en) | Specific immunophilin ligands with indole structure as antiasthmatics and immunosuppressants | |
ATE229495T1 (de) | Verfahren zur herstellung von n-acyl- aminosäureestern und n-acyl-aminoacetalen |